126 related articles for article (PubMed ID: 37534630)
1. PMS2 or PMS2CL? Characterization of variants detected in the 3' of the PMS2 gene.
Bouras A; Lefol C; Ruano E; Grand-Masson C; Wang Q
Genes Chromosomes Cancer; 2024 Jan; 63(1):e23193. PubMed ID: 37534630
[TBL] [Abstract][Full Text] [Related]
2. Detecting clinically actionable variants in the 3' exons of PMS2 via a reflex workflow based on equivalent hybrid capture of the gene and its pseudogene.
Gould GM; Grauman PV; Theilmann MR; Spurka L; Wang IE; Melroy LM; Chin RG; Hite DH; Chu CS; Maguire JR; Hogan GJ; Muzzey D
BMC Med Genet; 2018 Sep; 19(1):176. PubMed ID: 30268105
[TBL] [Abstract][Full Text] [Related]
3. Reclassification of a frequent African-origin variant from PMS2 to the pseudogene PMS2CL.
Chong AS; Chong G; Foulkes WD; Saskin A
Hum Mutat; 2020 Apr; 41(4):749-752. PubMed ID: 31916644
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive Mutation Analysis of PMS2 in a Large Cohort of Probands Suspected of Lynch Syndrome or Constitutional Mismatch Repair Deficiency Syndrome.
van der Klift HM; Mensenkamp AR; Drost M; Bik EC; Vos YJ; Gille HJ; Redeker BE; Tiersma Y; Zonneveld JB; García EG; Letteboer TG; Olderode-Berends MJ; van Hest LP; van Os TA; Verhoef S; Wagner A; van Asperen CJ; Ten Broeke SW; Hes FJ; de Wind N; Nielsen M; Devilee P; Ligtenberg MJ; Wijnen JT; Tops CM
Hum Mutat; 2016 Nov; 37(11):1162-1179. PubMed ID: 27435373
[TBL] [Abstract][Full Text] [Related]
5. Quantification of sequence exchange events between PMS2 and PMS2CL provides a basis for improved mutation scanning of Lynch syndrome patients.
van der Klift HM; Tops CM; Bik EC; Boogaard MW; Borgstein AM; Hansson KB; Ausems MG; Gomez Garcia E; Green A; Hes FJ; Izatt L; van Hest LP; Alonso AM; Vriends AH; Wagner A; van Zelst-Stams WA; Vasen HF; Morreau H; Devilee P; Wijnen JT
Hum Mutat; 2010 May; 31(5):578-87. PubMed ID: 20186688
[TBL] [Abstract][Full Text] [Related]
6. Characterisation of heterozygous
Wang Q; Leclerc J; Bougeard G; Olschwang S; Vasseur S; Cassinari K; Boidin D; Lefol C; Naïbo P; Frébourg T; Buisine MP; Baert-Desurmont S;
J Med Genet; 2020 Jul; 57(7):487-499. PubMed ID: 31992580
[TBL] [Abstract][Full Text] [Related]
7. Avoidance of pseudogene interference in the detection of 3' deletions in PMS2.
Vaughn CP; Hart KJ; Samowitz WS; Swensen JJ
Hum Mutat; 2011 Sep; 32(9):1063-71. PubMed ID: 21618646
[TBL] [Abstract][Full Text] [Related]
8. Clinical analysis of PMS2: mutation detection and avoidance of pseudogenes.
Vaughn CP; Robles J; Swensen JJ; Miller CE; Lyon E; Mao R; Bayrak-Toydemir P; Samowitz WS
Hum Mutat; 2010 May; 31(5):588-93. PubMed ID: 20205264
[TBL] [Abstract][Full Text] [Related]
9. A Comprehensive Strategy for Accurate Mutation Detection of the Highly Homologous PMS2.
Li J; Dai H; Feng Y; Tang J; Chen S; Tian X; Gorman E; Schmitt ES; Hansen TA; Wang J; Plon SE; Zhang VW; Wong LJ
J Mol Diagn; 2015 Sep; 17(5):545-53. PubMed ID: 26320870
[TBL] [Abstract][Full Text] [Related]
10. Molecular Background of Colorectal Tumors From Patients With Lynch Syndrome Associated With Germline Variants in PMS2.
Ten Broeke SW; van Bavel TC; Jansen AML; Gómez-García E; Hes FJ; van Hest LP; Letteboer TGW; Olderode-Berends MJW; Ruano D; Spruijt L; Suerink M; Tops CM; van Eijk R; Morreau H; van Wezel T; Nielsen M
Gastroenterology; 2018 Sep; 155(3):844-851. PubMed ID: 29758216
[TBL] [Abstract][Full Text] [Related]
11. Detection of
Okkels H; Lagerstedt-Robinsson K; Wikman FP; Hansen TVO; Lolas I; Lindberg LJ; Krarup HB
Genet Test Mol Biomarkers; 2019 Sep; 23(9):688-695. PubMed ID: 31433215
[No Abstract] [Full Text] [Related]
12. A Pathogenic Variant Reclassified to the Pseudogene
Fragoso-Ontiveros V; De la Fuente-Hernandez MA; Gonzalez-Osnaya V; Gamez-Rosales M; Perez-Montiel MD; Isla-Ortiz D; Cantu-De Leon DF; Alvarez-Gomez RM
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674914
[TBL] [Abstract][Full Text] [Related]
13. Improved multiplex ligation-dependent probe amplification analysis identifies a deleterious PMS2 allele generated by recombination with crossover between PMS2 and PMS2CL.
Wernstedt A; Valtorta E; Armelao F; Togni R; Girlando S; Baudis M; Heinimann K; Messiaen L; Staehli N; Zschocke J; Marra G; Wimmer K
Genes Chromosomes Cancer; 2012 Sep; 51(9):819-31. PubMed ID: 22585707
[TBL] [Abstract][Full Text] [Related]
14. Germline variants screening of MLH1, MSH2, MSH6 and PMS2 genes in 64 Algerian Lynch syndrome families: The first nationwide study.
Boumehdi AL; Cherbal F; Khider F; Oukkal M; Mahfouf H; Zebboudj F; Maaoui M
Ann Hum Genet; 2022 Nov; 86(6):328-352. PubMed ID: 36073783
[TBL] [Abstract][Full Text] [Related]
15. Homozygous germ-line mutation of the PMS2 mismatch repair gene: a unique case report of constitutional mismatch repair deficiency (CMMRD).
Ramchander NC; Ryan NA; Crosbie EJ; Evans DG
BMC Med Genet; 2017 Apr; 18(1):40. PubMed ID: 28381238
[TBL] [Abstract][Full Text] [Related]
16. The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations.
Senter L; Clendenning M; Sotamaa K; Hampel H; Green J; Potter JD; Lindblom A; Lagerstedt K; Thibodeau SN; Lindor NM; Young J; Winship I; Dowty JG; White DM; Hopper JL; Baglietto L; Jenkins MA; de la Chapelle A
Gastroenterology; 2008 Aug; 135(2):419-28. PubMed ID: 18602922
[TBL] [Abstract][Full Text] [Related]
17. The changing landscape of Lynch syndrome due to PMS2 mutations.
Blount J; Prakash A
Clin Genet; 2018 Jul; 94(1):61-69. PubMed ID: 29286535
[TBL] [Abstract][Full Text] [Related]
18. Germline PMS2 mutation screened by mismatch repair protein immunohistochemistry of colorectal cancer in Japan.
Sugano K; Nakajima T; Sekine S; Taniguchi H; Saito S; Takahashi M; Ushiama M; Sakamoto H; Yoshida T
Cancer Sci; 2016 Nov; 107(11):1677-1686. PubMed ID: 27589204
[TBL] [Abstract][Full Text] [Related]
19. Misclassification of a frequent variant from PMS2CL pseudogene as a PMS2 loss of function variant in Brazilian patients.
Segura AVC; da Silva SIO; Santiago KM; Brianese RC; Carraro DM; Torrezan GT
Fam Cancer; 2024 Jun; ():. PubMed ID: 38900223
[TBL] [Abstract][Full Text] [Related]
20. A case of early onset rectal cancer of Lynch syndrome with a novel deleterious PMS2 mutation.
Nomura S; Fujimoto Y; Yamamoto N; Sato Y; Ashihara Y; Kita M; Yamaguchi J; Ishikawa Y; Ueno M; Arai M
Jpn J Clin Oncol; 2015 Oct; 45(10):987-92. PubMed ID: 26232782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
